Dr George Tachas Director of Drug Discovery at Antisense Therapeutics said, “The Company is looking to capitalise on its deep understanding and experience in inflammatory and immune disease and the power of Somalogic’s large scale proteomics platform testing to help shed light on Long Neuro COVID- 19. Our goal is to identify new ways to better treat a disease that is negatively impacting the lives of millions of people around the world.
This will be the first study of its kind in the world in characterizing 7,000 blood plasma changes in Long Neuro COVID-19 patients* and so we look forward to working with Professor Koralnik and his team to generate this novel data to identify opportunities for the diagnosis, prognosis and treatment of Long Neuro COVID-19 and for the new intellectual property that we anticipate to emerge from this exciting collaboration.”The first results from the testing of Long Neuro COVID-19 patient samples are anticipated in mid-2022.
Look at the references that I have underlined…
Im 100% sure Anp has identified the Biomarkers for the treatment for Long Covid..$$$$
Chart, page-5639
-
- There are more pages in this discussion • 267 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PER (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
7.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $70.77M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 60948 | 7.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 7.9¢ | 101929 | 2 |
View Market Depth
| Last trade - 10.19am 18/07/2024 (20 minute delay) ? |
| PER (ASX) Chart |
Day chart unavailable